DC BioFuture
| Tuesday, October 5th – Friday, October 8th
Digital Event: |
Overview:
Join Outcome Capital’s Managing Director, Dr. Paul Mieyal to explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. For more information, please contact pmieyal@outcomecapital.com |
News
Outcome Capital Expands Pharmacy and Related Services Board to Enhance Strategic Advisory Capabilities and Drive Value Creation
Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced the expansion of its Pharmacy and Related Services Advisory Board.
Read MoreResources
Outcome Capital Life Science Market Pulse
Outcome Capital Life Science Market Pulse December 2025 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2026. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
